Mather Group LLC. lowered its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 25.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,639 shares of the medical instruments supplier's stock after selling 1,590 shares during the period. Mather Group LLC.'s holdings in Becton, Dickinson and Company were worth $799,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Saudi Central Bank purchased a new position in Becton, Dickinson and Company in the first quarter worth $26,000. Smallwood Wealth Investment Management LLC bought a new stake in shares of Becton, Dickinson and Company in the first quarter valued at $27,000. Alpine Bank Wealth Management bought a new stake in shares of Becton, Dickinson and Company in the first quarter valued at $29,000. Cornerstone Planning Group LLC raised its stake in shares of Becton, Dickinson and Company by 341.4% in the first quarter. Cornerstone Planning Group LLC now owns 128 shares of the medical instruments supplier's stock valued at $29,000 after buying an additional 99 shares during the period. Finally, Kelly Lawrence W & Associates Inc. CA bought a new stake in shares of Becton, Dickinson and Company in the first quarter valued at $31,000. Hedge funds and other institutional investors own 86.97% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Morgan Stanley boosted their price objective on Becton, Dickinson and Company from $196.00 to $197.00 and gave the company an "overweight" rating in a research note on Monday, August 11th. Barclays decreased their price objective on Becton, Dickinson and Company from $261.00 to $241.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. Wall Street Zen upgraded Becton, Dickinson and Company from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Wells Fargo & Company boosted their price objective on Becton, Dickinson and Company from $172.00 to $184.00 and gave the company an "equal weight" rating in a research note on Friday, August 8th. Finally, Piper Sandler reiterated a "neutral" rating and set a $200.00 price objective (up from $185.00) on shares of Becton, Dickinson and Company in a research note on Friday, August 8th. Four investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $213.09.
Check Out Our Latest Stock Report on Becton, Dickinson and Company
Insider Transactions at Becton, Dickinson and Company
In other news, Director Claire Fraser sold 917 shares of the company's stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $187.50, for a total value of $171,937.50. Following the completion of the transaction, the director directly owned 22,226 shares in the company, valued at approximately $4,167,375. This represents a 3.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael David Garrison sold 1,185 shares of the stock in a transaction dated Friday, July 18th. The shares were sold at an average price of $180.29, for a total value of $213,643.65. Following the sale, the executive vice president owned 4,887 shares of the company's stock, valued at $881,077.23. This represents a 19.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,965 shares of company stock valued at $551,536 over the last quarter. Company insiders own 0.36% of the company's stock.
Becton, Dickinson and Company Price Performance
Shares of NYSE BDX opened at $180.86 on Friday. The firm has a market capitalization of $51.84 billion, a P/E ratio of 32.53, a P/E/G ratio of 1.50 and a beta of 0.27. The company has a quick ratio of 0.62, a current ratio of 1.10 and a debt-to-equity ratio of 0.69. The stock's 50-day simple moving average is $188.15 and its two-hundred day simple moving average is $189.25. Becton, Dickinson and Company has a twelve month low of $163.33 and a twelve month high of $251.99.
Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share for the quarter, topping analysts' consensus estimates of $3.40 by $0.28. The business had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.50 billion. Becton, Dickinson and Company had a return on equity of 16.23% and a net margin of 7.51%.The company's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company earned $3.50 EPS. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. As a group, equities analysts anticipate that Becton, Dickinson and Company will post 14.43 EPS for the current fiscal year.
Becton, Dickinson and Company Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 8th will be issued a $1.04 dividend. This represents a $4.16 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, September 8th. Becton, Dickinson and Company's dividend payout ratio is presently 74.82%.
About Becton, Dickinson and Company
(
Free Report)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Becton, Dickinson and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.
While Becton, Dickinson and Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
